Renishaw plc (LON:RSW) has received a consensus recommendation of “Hold” from the eight brokerages that are presently covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a sell rating and five have given a hold rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is GBX 3,432.57 ($46.20).

A number of equities analysts have recently weighed in on the company. Citigroup restated a “neutral” rating and issued a GBX 470 ($6.33) target price on shares of Renishaw in a research note on Monday, October 30th. Deutsche Bank upped their price objective on Renishaw from GBX 3,630 ($48.86) to GBX 4,255 ($57.27) and gave the company a “sell” rating in a research note on Monday, December 4th. Numis Securities downgraded Renishaw to a “hold” rating and set a GBX 5,200 ($69.99) price objective on the stock. in a research note on Tuesday, December 5th. Barclays upped their price objective on Renishaw from GBX 2,620 ($35.26) to GBX 3,880 ($52.22) and gave the company an “underweight” rating in a research note on Thursday, August 17th. Finally, Investec reiterated a “hold” rating on shares of Renishaw in a research note on Friday, August 25th.

Renishaw (LON:RSW) opened at GBX 5,050.12 ($67.97) on Friday. Renishaw has a 12 month low of GBX 2,413 ($32.48) and a 12 month high of GBX 5,635 ($75.84).

ILLEGAL ACTIVITY NOTICE: “Renishaw plc (RSW) Receives Average Recommendation of “Hold” from Brokerages” was published by American Banking News and is the property of of American Banking News. If you are viewing this story on another domain, it was stolen and republished in violation of United States and international copyright law. The original version of this story can be accessed at

Renishaw Company Profile

Renishaw plc is a metrology company. The Company operates through two segments: metrology and healthcare. The Company’s metrology products are used in the fields of industrial automation and motion systems. The healthcare products include engineering solutions for stereotactic neurosurgery, diagnosis of infectious diseases, analytical tools that identify and characterize the chemistry and structure of materials, supply of implants to hospitals and specialist design centers for craniomaxillofacial surgery, and products and services that allow dental laboratories to manufacture dental restorations.

Analyst Recommendations for Renishaw (LON:RSW)

Receive News & Ratings for Renishaw plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renishaw plc and related companies with's FREE daily email newsletter.